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Air Pollution and Cardiovascular Injury
Epidemiology, Toxicology, and Mechanisms
Boris Z. Simkhovich, MD, PHD,*† Michael T. Kleinman, PHD,‡ Robert A. Kloner, MD, PHD, FACC*†
Los Angeles and Irvine, California
Recent epidemiologic studies show that increased levels of air pollutants are positively associated with cardio-
vascular morbidity and mortality. Inhalation of air pollutants affects heart rate, heart rate variability, blood pres-
sure, vascular tone, blood coagulability, and the progression of atherosclerosis. Several categories within the
general population (i.e., people with pre-existing cardiovascular disease and diabetic and elderly individuals) are
considered to be more susceptible to air pollution–mediated cardiovascular effects. Major mechanisms of
inhalation-mediated cardiovascular toxicity include activation of pro-inflammatory pathways and generation of
reactive oxygen species. Although most studies focus on the influence of systemic effects, recent studies indi-
cate that ultrafine particles may be translocated into the circulation and directly transported to the vasculature
and heart where they can induce cardiac arrhythmias and decrease cardiac contractility and coronary
flow. (J Am Coll Cardiol 2008;52:719–26) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.05.029p
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pir pollution significantly increases both morbidity and
ortality in the general population (1–4). High respiratory
ulnerability has been widely acknowledged as a major
omponent of the adverse health effects of air pollution
5,6). However, during the last 15 years air pollution–
nduced cardiovascular toxicity has become the focus of
ntensive studies among cardiologists and specialists in
nvironmental medicine (7–12). In the current review we
ummarize data regarding the cardiovascular toxicity of air
ollution in the general population and discuss mechanisms
f the effects of air pollutants on cardiac muscle and
asculature.
istorical Perspective
t was not until 1872 that Robert Angus Smith published
ne of the first voluminous air pollution–related studies.
he book was entitled “Air and Rain. The Beginning of
hemical Climatology” (13). Smith pioneered studies of air
ollutants as hazardous components of urban air and spe-
ifically analyzed their presence in “acid rains.”
The 20th century was marked by several major incidents
aused by acute air pollution. In December of 1930 a
ombination of high atmospheric pressure and mild winds
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Manuscript received January 14, 2008; revised manuscript received May 14, 2008,
ccepted May 19, 2008.ointed toward a narrow valley created a thick and almost
otionless fog in the Meuse Valley in Belgium. Between
ecember 4 and 5 a total of 60 deaths caused by the fog
ccurred. Most of the deaths were in the small town of
ngis (Belgium). Investigation of this environmental inci-
ent revealed that the thick low fog entrapped pollutants
rom chimney exhausts and created a toxic cloud that
esulted in these fatalities (14).
In October 1948, an environmental disaster took place
n Donora, Pennsylvania. On October 26, industrial
ollutants from a local smelting plant started to accumu-
ate in the air over Donora, a small industrial town some
0 miles south of Pittsburgh. The incident caused 20
udden deaths. An estimate indicated that from 5,000 to
,000 people (of 14,000 residents) became ill. In addition
o 20 fatalities there were 400 hospital stays (15,16).
In 1952 a major environmental incident occurred in
reater London. From December 5 to 9, a heavy fog laden
y pollutants from local stoves and industrial plants almost
aralyzed the entire city. There was a 48% increase in all
ospital admissions and a 163% increase in respiratory
isease–related admissions. During and shortly after the
ncident, the numbers of deaths were significantly elevated.
retrospective analysis indicated that there were almost
2,000 more deaths from December 1952 through February
953 (17,18).
These environmental incidents triggered worldwide
egislative activities that resulted in regulatory acts aimed
t limiting the toxic and sometimes deadly effects of air
ollutants (e.g., establishment of the Clean Air and Air
uality Acts in the U.S. in 1963 and 1967, respectively).
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Air Pollution and Cardiovascular Injury August 26, 2008:719–26Size and Composition
of Ambient Particles
Ambient particles include coarse
particles with aerodynamic di-
ameter (AD) 2.5 to 10 m
(PM10), fine particles (AD 2.5
m; PM2.5), and ultrafine parti-
cles (AD 0.1 m; UFPs). The
chemical composition of particles
varies greatly and depends on nu-
merous geographical, meteorolog-
ical, and source-specific variables.
Generally, ambient particles in-
clude inorganic components (sul-
fates, nitrates, ammonium, chlo-
ride, trace metals), elemental and
organic carbon, crystal materials,
biological components (bacteria,
spores, pollens), and adsorbed
volatile and semivolatile organic
ompounds (19). In addition, ambient particles, when
ixed with atmospheric gases (ozone, sulfur and nitric
xides, and carbon monoxide [CO]), can generate ambient
erosols.
Particulate air pollutants are derived from both human
nd natural activities. The PM10 particles related to human
ctivities come from road and agricultural dust, tire wear
missions, wood combustion, construction and demolition
orks, and as a result of mining operations. Natural sources
f PM10 include windblown dust and wildfires. Fine
articles are mainly generated by gas to particle conversions
nd during fuel combustion and industrial activities. Major
ources of PM2.5 include power plants, oil refinery and
etal processing facilities, tailpipe and brake emissions from
obile sources, residential fuel combustion, and wildfires.
he primary contributors to UFPs are tailpipe emissions
rom mobile sources (motor vehicles, aircrafts, and marine
essels).
orbidity and Mortality Caused by Air Pollution
he relationships between air pollution and both morbidity
nd mortality has been thoroughly reviewed by Pope and
ockery (20). A few key studies are highlighted here to
rovide additional perspective.
hort-term effects. Short-term exposures to increased lev-
ls of air pollutants are directly linked to increased morbidity
as indicated by increased hospital admissions). An increase
n PM10 level by 10 g/m3 was associated with 1.27%,
.45%, and 2.00% increases in hospital admissions for heart
isease, chronic obstructive pulmonary disease, and pneu-
onia, respectively (data for Chicago area hospitals for years
988 to 1993) (21). A 9-year observation in 10 U.S. cities
evealed similar increases in hospital admissions for cardio-
Abbreviations
and Acronyms
AD  aerodynamic
diameter
CAP  concentrated
ambient particle
HR  heart rate
HRV  heart rate variability
MI  myocardial infarction
PM  particulate matter
PM10  coarse particle(s)
(diameter <10 m)
PM2.5  fine particle(s)
(diameter <2.5 m)
ROS  reactive oxygen
species
UAP  urban air particle
UFP  ultrafine particle
(diameter <0.1 m)ascular disease and pneumonia for each 10-g/m3 increase rn PM10 concentration (22). In Ontario, Canada, a 6-year
eriod of observation revealed that a 13-g/m3 increase in
mbient particulate sulfate resulted in statistically significant
ncreases in hospital admissions for respiratory and cardio-
ascular diseases (3.7% and 2.8%, respectively) (23).
Short-term effects of air pollution on mortality are
nalyzed in time-series studies, which cover days and/or
eeks before the death and establish association between
aily deaths and daily changes in air pollution levels. Several
hort-term studies of mortality in communities demon-
trated increases in daily death in relationship to increases in
he levels of air pollution. In Coachella Valley, California,
aily counts of total deaths indicated that an increase in
M10 concentration by 10 g/m3 was associated with a 1%
ncrease in total mortality (24). Analysis of daily deaths in
0 U.S. cities indicated that there was a 0.67% increase in
otal daily death for a 10-g/m3 increase in PM10 concen-
ration. The increase was more pronounced for out-of-
ospital deaths and averaged 0.89% (25). A European study
APHEA2 [Air Pollution and Health: A European Ap-
roach]) demonstrated that PM10 and black smoke were
redictors of daily death in studied areas. When the ambient
oncentrations of PM10 and black smoke were increased by
0 g/m3, the total number of daily deaths was increased by
.7% and 0.5%, respectively (26). In the U.S., the National
orbidity, Mortality, and Air Pollution Study indicated a
.41% increase in total mortality in response to a 10-g/m3
ncrease in PM10 in ambient air (27).
ong-term effects. Morbidity (as indicated by accelerated
rogression of atherosclerosis) is significantly increased by
ong-term exposure to increased levels of air pollutants
11,28).
Long-term effects of air pollution on mortality are inves-
igated in cohort studies. These studies cover years of
xposure, include large numbers of participants, and provide
nformation on life-shortening effects of air pollution
29,30). A large-scale study based on 14- to 16-year
ortality in 8,111 adults in 6 U.S. cities (HSCS [Harvard
ix Cities Study]) demonstrated a close relationship be-
ween the levels of PM2.5 and lung cancer and cardiopul-
onary mortality (2). Extended follow-up of the HSCS
ound that the increase in the relative risk of mortality
veraged 16% per 10-g/m3 increase in the PM2.5 concen-
ration (risk ratio 1.16) (31). One of the most comprehen-
ive studies, known as the ACS (American Cancer Society)
tudy (1982 through 1989), linked individual health risks for
esidents of approximately 150 U.S. cities with ambient air
uality in those cities (risk ratio 1.17 for all-cause mortality
ue to the increased levels of PM2.5) (32). A subsequent
ollow-up of 500,000 ACS participants through December
1, 1998 indicated that there was a 4%, 6%, and 8%
ncreased risk of all-cause, cardiopulmonary, and lung can-
er mortalities, respectively, per each 10-g/m3 increase in
M2.5 (33).
Long-term cohort studies suggest consistently higherelative risk estimates/unit exposure than short-term stud-
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August 26, 2008:719–26 Air Pollution and Cardiovascular Injuryes. The most likely explanation for this is that chronic
tudies can capture cumulative health effects due to long-
erm air pollutant exposure, whereas short-term studies
eflect acute effects (20). Nonetheless, both time-series and
ohort studies undeniably indicate that air pollution in-
reases morbidity and mortality in the general population.
ardiovascular Events Triggered by Air Pollution
nalysis of daily mortality data for 20 of the largest U.S.
ounties for years 1987 through 1994 demonstrated that there
as a 0.68% increase in cardiovascular and respiratory deaths
or each 10-g/m3 increase in PM10 in ambient air (34).
eta-analysis of data collected during the ACS for years 1979
hrough 2000 indicated that long-term exposure to air pollut-
nts was associated with an increased mortality risk in the
schemic heart disease category (risk ratio 1.18) and combined
ysrhythmias, heart failure, and cardiac arrest category (risk
atio 1.13) for every 10-g/m3 increase in PM2.5 (9).
A 4-year study in 204 counties in the U.S. and a 10-year
tudy in 5 major European cities indicated that hospital
dmissions for cardiovascular diseases are positively associ-
ted with increased levels of air pollution (35,36). When
73,566 emergency cardiovascular admissions in London
ospitals from April 1, 1987 through March 31, 1994 were
nalyzed, positive associations were found between myocar-
ial infarction (MI) and black smoke and atmospheric gases
nitrogen dioxide [NO2], CO, and sulfur dioxide [SO2])
nd between angina and black smoke. The authors con-
luded that exposure-prevention measures could have saved
t least 6,000 patients (37). The significance of air pollutants
n triggering MI described in the London-based study was
onfirmed by Peters et al. (38) in the Determinants of
yocardial Infarction Onset Study in the greater Boston
rea. In addition, recent epidemiological analysis by Welle-
ius et al. (8) in 7 U.S. cities, including 292,918 hospital
dmissions for congestive heart failure (CHF), revealed that
n increase in PM10 by 10 g/m3 resulted in a 0.72%
ncrease in the daily admissions for CHF.
There are several categories of individuals within the
eneral population that might be at higher risk for air
ollution–mediated cardiovascular morbidity. These catego-
ies include people with pre-existing cardiovascular disease,
eople with diabetes, and elderly individuals (39–43). A
ontrolled human study in 20 men with prior MI indicated
hat inhalation of diluted diesel exhaust particles (ambient
oncentration 300 g/m3, median AD 54 nm) resulted in
reater ST-segment depression during exercise compared
ith exercised participants that inhaled filtered air (44).
Because the chemical composition of ambient particles
aries greatly between different geographical areas, it is
ifficult to identify specific component(s) that elicit cardio-
ascular toxicity. Animal studies indicate that transition
etals and carbonaceous material from particulate matter
PM) mediate some cardiotoxic effects of particulate air
ollutants (45,46). Gaseous components of ambient aerosols iozone [O3], SO2, NO2, and CO) were shown to be
ssociated with the occurrence of acute MI, increased all
ardiac hospital admissions, and exacerbated exercise-
elated angina in stable angina patients (37,47–49). Most of
hese components of air pollution are derived from motor
ehicles and industrial sources.
ffects of Air Pollutants
n Cardiovascular Indexes in Humans
ir pollution exposure results in significant changes in many
ardiovascular indexes. Some of the effects (i.e., changes in
he heart rate [HR], heart rate variability [HRV], blood
ressure, vascular tone, and blood coagulability) develop
cutely in response to increased levels of ambient particles.
t the same time the progression of atherosclerosis accel-
rates as a result of a more prolonged (chronic) exposure to
ncreased concentration of particulate air pollutants.
R and HRV. A study of residents from a Boston housing
ommunity (median age 73.3 years) demonstrated that
xposure to PM2.5 (mean concentration 15.5 g/m3) was
ssociated with a decreased HR (50). In contrast, an
ncrease in ambient concentration of PM10 on a previous
ay by 100 g/m3 significantly raised the odds of an
ncrease in HR by 5 to 10 beats/min (51). These results
ndicate that air pollution can dysregulate the autonomic
ervous system and that the type of particles and their
oncentrations might affect HR in a variable fashion.
urther evidence regarding the effects of air pollution on
utonomic cardiac control was presented in studies investi-
ating changes in HRV with regard to the air pollution
evels. Several studies demonstrated that air pollution is
ssociated with decreased HRV (as indicated by declines in
D of all normal RR intervals, SDNN, and in square root
f the mean of the squared differences between adjacent
ormal RR intervals, r-MSSD) (40,43,50,52). These find-
ngs are important because according to the Framingham
eart Study, decreases in SDNN and r-MSSD are associ-
ted with increased cardiac risk (53).
lood pressure. Data analysis from 62 ambulatory cardiac
ehabilitation patients indicated that 120 h of exposure to
he 10th through 90th percentile levels of PM2.5 (mean
oncentration 10.5 g/m3) was associated with increases in
esting systolic and diastolic pressures by 2.7 and 2.8 mm
g, respectively. In exercised subjects with resting HR70
eats/min, 48-h exposure to the 10th through 90th percen-
ile levels of PM2.5 (mean concentration 13.9 g/m3)
esulted in a highly significant increase in diastolic blood
ressure by 6.95 mm Hg and somewhat less significant (p
.11) increase in the mean arterial pressure by 4.3 mm Hg,
ith no effect on systolic pressure (54). The MONICA
Monitor Trends in Cardiovascular Diseases Study) trial in
ermany revealed that there was a modest increase from
.79 to 2.37 mm Hg in the systolic pressure per 90 g/m3ncrease in total ambient air particulates. These effects of
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Air Pollution and Cardiovascular Injury August 26, 2008:719–26ollutants were exacerbated in patients with underlying high
lood viscosity and high HRs (55).
ascular tone and reactivity. In the first controlled study
imed at investigating the effects of air pollutants on human
ascular function, it was shown that inhalation of concentrated
mbient particles (CAPs) plus ozone (approximately 150
g/m3 and 120 parts/billion, respectively) for 2 h by healthy
olunteers caused a significant decrease in brachial artery
iameter by 0.09 mm (56). Increased levels of PM2.5 and
lack carbon were associated with decreases in endothelium-
ependent and endothelium-independent vascular reactivity in
atients with type II diabetes (42).
lood coagulability. Experimental data demonstrated that
FPs could act as prothrombotic factors in mice and
amsters (57,58). The MONICA survey indicated that
lasma viscosity was increased in both men and women
ubjected to a 1985 air pollution episode in Augsburg,
ermany (59). Analysis of levels of air pollution and
hanges in global coagulation parameters in 1,218 indi-
iduals from the Lombardia Region in Italy revealed that
igh air pollution was associated with shorter prothrom-
in time (60).
therosclerosis. In animal studies chronic inhalation of
oncentrated UFPs and PM2.5 or intrapharyngeal instilla-
ion of PM10 increased the severity of atherosclerotic aortic
esions in apolipoprotein E-deficient mice and Watanabe
yperlipidemic rabbits (61–63). In human studies involving
98 residents of the Los Angeles basin, Kunzli et al. (28)
ound a 5.9% increase in the carotid artery intima-media
hickness per 10 g/m3 increase of PM2.5 in the ambient
ir. In a study investigating the role of traffic-related,
ong-term exposure to PM2.5 (mean concentration 22.8
g/m3) in 4,494 participants, a 50% reduction in the
istance between the residence and a main road resulted in
10.2% increase in coronary artery calcification (11). These
tudies support the concept that air pollution is causing
rogression of atherosclerosis.
echanisms of Air Pollution-Induced Toxicity
ulmonary toxicity. The general consensus is that once
eposited in the lungs, air pollutants trigger an inflammation-
elated cascade (64,65). Intra-tracheal instillation of ambi-
nt particles was shown to induce direct inflammatory
esponse in rat lungs. Pre-treatment with an antioxidant
dimethylthiourea) significantly reduced inflammation in
article-treated groups (66–68).
Ghio and Devlin (69) instilled aqueous extracts of PM,
ollected in the Utah Valley before the closure of a local
teel mill, during its closure, and after its reopening, into the
ungs of healthy volunteers. The percentage of neutrophils
nd concentrations of fibronectin and alpha-1–antitripsin
both indicators of injury to lung tissue) in bronchoalveolar
avage fluids were increased in volunteers who received
xtracts from samples obtained before the closure and after
he reopening of the steel mill. Pro-inflammatory effects of phese extracts correlated with their abilities to generate
hiobarbituric acid reactive products in vitro (index of
eactive oxygen species [ROS] generation).
These results clearly indicate that pulmonary inflamma-
ion induced by ambient particles could be triggered by an
OS-dependent mechanism and that source-specific con-
tituents can play an important role in PM toxicity.
ardiovascular toxicity. In a dog ischemia model, inhala-
ion exposure to CAPs significantly increased ischemic injury
o the heart muscle (as evidenced by an increased ST-segment
levation) during 5-min coronary occlusion (70). Inhalation
xposure of Wistar-Kyoto rats to combustion-derived PM
esulted in active and chronic inflammation within the myo-
ardium and fibrosis in the ventricles and in the interventricular
eptum (71). Intratracheal instillation of ambient UFPs to mice
ollowed by 20-min coronary artery ligation and 2 h of
eperfusion 24 h after the inhalational exposure to pollutants
ncreased the amount of neutrophils in the reperfused myocar-
ium and significantly increased the size of MI (72).
In human studies, exposure to particulate air pollutants
ncreased circulating levels of C-reactive protein and other
nflammatory markers, increased blood coagulability, caused
ndothelial dysfunction and acute vasoconstriction, and
xacerbated myocardial ischemia (43,44,56,59,73,74). In-
reased concentration of C-reactive protein is a bio-
arker of systemic inflammation and an independent
redictor of cardiovascular disease (75,76). Systemic
nflammation is a well-known risk factor for developing
therosclerosis (77). Pro-thrombotic changes in blood
nd endothelial dysfunction and acute changes in vascular
one are important factors in triggering and/or exacerbat-
ng ischemic heart disease (78).
OS and the cardiovascular system. In lungs, particulate
ir pollutants were shown to trigger pro-inflammatory signal-
ng via an ROS-dependent mechanism (64–69). Considering
he possibility that UFPs are capable of reaching the heart and
ther remote organs via the vasculature (79), particle-mediated
oxic effects could be realized at the level of the heart and
ardiac vessels. Reactive oxygen species generation in the heart
uscle and/or in the endothelial cells could be one of the
echanisms responsible for the toxic effects of UFPs.
Increased amounts of ROS were shown to be closely
nvolved in myocardial stunning, necrosis, vascular dysfunction,
nd apoptosis, and some of their effects were effectively blocked
y free radical scavengers (80,81). In clinical settings, ROS
ere linked to the arrhythmias observed in patients undergoing
oronary artery bypass surgery and were suggested to be
nvolved in the pathogenesis of heart failure (82–84).
Among other pathological cardiovascular conditions trig-
ered by or developed with the direct involvement of ROS,
therosclerosis is a noteworthy one (85).
articulate air pollutants and ROS in the heart. Inhala-
ion exposure to CAPs resulted in an increase in the in situ
hemiluminescence (a measure of ROS generation) in rat
ungs and heart (86). Intratracheal instillation of urban air
articles (UAPs) or inhalation exposure to CAPs resulted
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August 26, 2008:719–26 Air Pollution and Cardiovascular Injuryn increased oxidative stress in the heart and was accom-
anied by increased HRV 30 min after the exposure. The
ntioxidant N-acetyl cysteine prevented both the accu-
ulation of oxidants and changes in the HRV caused by
APs. Both the beta-1 adrenergic antagonist (atenolol)
nd the muscarinic receptor antagonist (glycopyrrolate)
iven before the instillation of UAPs prevented oxidative
tress caused by particulate pollutants. These results were
lso confirmed with inhalation exposure to CAPs. The
uthors concluded that particulate pollutants caused ox-
Figure 1 Pathophysiological Mechanisms of Lung- and Circulat
Inhaled ambient air particles increase production of reactive oxygen species (ROS)
The ROS and pro-inflammatory cytokines released into the blood stream affect aut
blood pressure, vascular tone and reactivity, blood coagulability, and progression o
oxidative stress and pro-inflammatory changes directly in the cardiac muscle and v
exacerbate myocardial ischemia and increase cardiovascular mortality. CRP  C-re
Flewell.dative stress via changes in autonomic signaling, and ehanges in the levels of oxidants are associated with
lterations in HRV (87).
Intra-tracheal instillation of diesel exhaust particles in rats
bolished the protective effect of ischemic pre-conditioning
gainst reperfusion arrhythmias. The protective effect of isch-
mic pre-conditioning was restored when rats were given
ntravenous injections of superoxide dismutase (88). These
esults indicated that pollutants from the diesel exhaust might
ffect the heart muscle via ROS-mediated mechanism. The
nvolvement of ROS in cardiac injury was also confirmed in
ediated Cardiovascular Toxicity of Particulate Air Pollutants
airways and lung alveoli and stimulate local inflammatory reaction in the lungs.
c cardiac control (heart rate, heart rate variability, and cardiac contractility),
rosclerosis. Ultrafine particles may translocate into the circulation and induce
ture. Lung- and circulation-mediated and direct pathophysiological mechanisms
protein; IL  interleukin; TNF  tumor necrosis factor. Figure illustration by Robion-M
in the
onomi
f athe
ascula
activexperiments showing that direct cardiotoxic effects of diesel
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Air Pollution and Cardiovascular Injury August 26, 2008:719–26xhaust particles in neonatal rat cardiomyocytes could be
ttenuated by free radical scavenging systems (89).
articulate air pollutants and ROS-mediated effects on
he vasculature. Diesel exhaust particles were shown to
nhibit endothelium-dependent relaxation in rat thoracic aorta
ia a free radical–dependent mechanism (90). The ROS-
ediated effects of particles on endothelial cells might be
ssociated with the toxic organic components present in PM.
he direct cytotoxic effects of organic compounds from diesel
xhaust particles on cultured human pulmonary artery endo-
helial cells were attenuated by free radical scavengers and
ntioxidants (91). Induction of oxidative stress in endothelial
ells from the rat heart vasculature was also reported for organic
xtracts of PM2.5 (92). An ROS-related mechanism for
article-induced impairments of vascular tone and reactivity
as suggested in clinical studies involving both healthy volun-
eers and patients with type II diabetes (42,56).
irect and acute effects of ultrafine air pollutants. It has
een suggested that after inhalation exposure ultrafine
articles may translocate into the blood stream and can be
ound in remote organs (e.g., the heart) (79). This finding
uggests that UFPs could induce direct cardiovascular toxic
ffects independent of their passage through the lungs. In an
n vivo experiment, UFPs isolated from ambient air and
njected intravenously to anesthetized rats caused an in-
rease in the left ventricle ejection fraction without affecting
he heart rate (93). This circulation-mediated effect could be
ttributed either to an increase in sympathetic tone or to a
irect inotropic effect of ultrafine air pollutants. The ob-
erved increase in the ejection fraction has the potential to
e harmful in patients with pre-existing coronary artery
isease by increasing oxygen demand in the setting of
mpeded oxygen supply. Intravenous injection of UFPs
solated from the exhaust of a small diesel caused premature
entricular beats. When UFPs from the same source were
irectly instilled into the perfusion line of isolated
angendorff-perfused rat hearts, both cardiac contractility
dP/dt) and coronary flow were dramatically decreased (by
6% and 32%, respectively) (93). The direct and acute
ffects of UFP most likely could be explained by their ability
o generate ROS, which were shown to cause both myocar-
ial stunning and endothelial dysfunction (80,81,90).
The comparison of the in vivo data (increased ejection
raction) versus the in vitro data (direct cardiodepressant
ffects) indicates that resultant cardiac effects of UFPs might
epend on the combination of their circulation-mediated
nd direct cardiotoxic mechanisms. Figure 1 presents pos-
ible mechanisms of lung- and circulation-mediated cardio-
oxicity and direct cardiac effects of ambient air pollutants.
The direct and acute effects of UFPs were confirmed in
angendorff-perfused hearts obtained from young adult and
ld Fisher 344/Brown Norway rats and in hearts from
pontaneously hypertensive rats (SHR) and their respective
ontrol subjects (i.e., Wistar-Kyoto rats). Young and old
earts demonstrated equal functional deterioration and
qual decreases in coronary flow in response to UFPsntroduced directly into the cardiac vasculature via the
angendorff perfusion line, and the response to the cardio-
oxic effects of UFPs was not worsened in the hearts from
pontaneously hypertensive rats (94,95). In summary, these
tudies indicate that UFPs can directly and acutely affect
ardiac contractility and coronary flow independently of
ung-mediated mechanisms and that the direct cardiotoxic
ffects are unaffected by age or preexisting cardiovascular
isease.
onclusions
ata from numerous studies unequivocally indicate that air
ollution is directly linked to the adverse cardiovascular
utcomes in the general population, and effects are seen at
evels at or below existing air quality standards. The major
trategy in decreasing the harmful effects of air pollution is
he reduction of air pollutants themselves. However, study-
ng the epidemiology and the mechanisms of air pollution–
elated health effects (including cardiovascular toxicity) will
ossibly identify specific causal agents that can be better
egulated and increase the effectiveness of our efforts to
educe the risk of developing air pollution–related health
roblems.
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